Value of Enhancer of Zeste Homolog 2 (EZH2) for Determining Prognosis in Colon Cancer
Introduction: It has been reported that Enhancer of Zeste Homolog 2 (EZH2) enhancer is expressed in Colorectal Cancer (CRC), but there are only limited findings of its overexpression with prognosis in CRC. Aim: To investigate the association between EZH2 expression and clinicopathologic variables a...
Main Authors: | Nassrin Gholami, Zohreh Sanaat, Roya Dolatkhah, Alireza Nikanfar, Ali Esfahani, Amin Danandehmehr, Ashraf Akhrjou, Faris Farassati |
---|---|
Format: | Article |
Language: | English |
Published: |
JCDR Research and Publications Private Limited
2020-03-01
|
Series: | Journal of Clinical and Diagnostic Research |
Subjects: | |
Online Access: | https://jcdr.net/articles/PDF/13559/43176_CE[Ra1]_F(KM)_PF1_(AJ_OM)_PN(SL).pdf |
Similar Items
-
The Prognostic Value of Different Molecular Subtypes of Breast Cancer in Relation to Enhancer-of-Zeste Homologue 2 Expression
by: Zohreh Sanaat, et al.
Published: (2019-07-01) -
Enhancer of Zeste homolog 2 (EZH2) induces epithelial-mesenchymal transition in endometriosis
by: Qi Zhang, et al.
Published: (2017-07-01) -
Plasma Cell Rich Osteomyelitis: A Rare Entity
by: PRAKHAR MAHESHWARI, et al.
Published: (2020-11-01) -
Enhancer of zeste homolog 2 (EZH2) in pediatric soft tissue sarcomas: first implications
by: Giordano Antonio, et al.
Published: (2011-05-01) -
A toolbox of nanobodies developed and validated for use as intrabodies and nanoscale immunolabels in mammalian brain neurons
by: Jie-Xian Dong, et al.
Published: (2019-09-01)